Mental state deterioration after switching from brand-name to generic olanzapine in an adolescent with bipolar affective disorder, autism and intellectual disability: a case study

BACKGROUND: The appropriateness of use of generic instead of brand-name medication remains unresolved and controversial in several areas of medicine. Some evidence suggestive of variations in bioavailability and clinical effectiveness between different formulations make policy decisions occasionally...

Descripción completa

Detalles Bibliográficos
Autores principales: Samuel, Rani, Attard, Azizah, Kyriakopoulos, Marinos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850677/
https://www.ncbi.nlm.nih.gov/pubmed/24094081
http://dx.doi.org/10.1186/1471-244X-13-244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850677/
https://www.ncbi.nlm.nih.gov/pubmed/24094081
http://dx.doi.org/10.1186/1471-244X-13-244

Ejemplares similares